Cargando…
1-methylnicotinamide and its structural analog 1,4-dimethylpyridine for the prevention of cancer metastasis
BACKGROUND: 1-methylnicotinamide (1-MNA), an endogenous metabolite of nicotinamide, has recently gained interest due to its anti-inflammatory and anti-thrombotic activities linked to the COX-2/PGI(2) pathway. Given the previously reported anti-metastatic activity of prostacyclin (PGI(2)), we aimed t...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944260/ https://www.ncbi.nlm.nih.gov/pubmed/27412454 http://dx.doi.org/10.1186/s13046-016-0389-9 |
_version_ | 1782442739781074944 |
---|---|
author | Blazejczyk, Agnieszka Switalska, Marta Chlopicki, Stefan Marcinek, Andrzej Gebicki, Jerzy Nowak, Marcin Nasulewicz-Goldeman, Anna Wietrzyk, Joanna |
author_facet | Blazejczyk, Agnieszka Switalska, Marta Chlopicki, Stefan Marcinek, Andrzej Gebicki, Jerzy Nowak, Marcin Nasulewicz-Goldeman, Anna Wietrzyk, Joanna |
author_sort | Blazejczyk, Agnieszka |
collection | PubMed |
description | BACKGROUND: 1-methylnicotinamide (1-MNA), an endogenous metabolite of nicotinamide, has recently gained interest due to its anti-inflammatory and anti-thrombotic activities linked to the COX-2/PGI(2) pathway. Given the previously reported anti-metastatic activity of prostacyclin (PGI(2)), we aimed to assess the effects of 1-MNA and its structurally related analog, 1,4-dimethylpyridine (1,4-DMP), in the prevention of cancer metastasis. METHODS: All the studies on the anti-tumor and anti-metastatic activity of 1-MNA and 1,4-DMP were conducted using the model of murine mammary gland cancer (4T1) transplanted either orthotopically or intravenously into female BALB/c mouse. Additionally, the effect of the investigated molecules on cancer cell-induced angiogenesis was estimated using the matrigel plug assay utilizing 4T1 cells as a source of pro-angiogenic factors. RESULTS: Neither 1-MNA nor 1,4-DMP, when given in a monotherapy of metastatic cancer, influenced the growth of 4T1 primary tumors transplanted orthotopically; however, both compounds tended to inhibit 4T1 metastases formation in lungs of mice that were orthotopically or intravenously inoculated with 4T1 or 4T1-luc2-tdTomato cells, respectively. Additionally, while 1-MNA enhanced tumor vasculature formation and markedly increased PGI(2) generation, 1,4-DMP did not have such an effect. The anti-metastatic activity of 1-MNA and 1,4-DMP was further confirmed when both agents were applied with a cytostatic drug in a combined treatment of 4T1 murine mammary gland cancer what resulted in up to 80 % diminution of lung metastases formation. CONCLUSIONS: The results of the studies presented below indicate that 1-MNA and its structural analog 1,4-DMP prevent metastasis and might be beneficially implemented into the treatment of metastatic breast cancer to ensure a comprehensive strategy of metastasis control. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13046-016-0389-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4944260 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-49442602016-07-15 1-methylnicotinamide and its structural analog 1,4-dimethylpyridine for the prevention of cancer metastasis Blazejczyk, Agnieszka Switalska, Marta Chlopicki, Stefan Marcinek, Andrzej Gebicki, Jerzy Nowak, Marcin Nasulewicz-Goldeman, Anna Wietrzyk, Joanna J Exp Clin Cancer Res Research BACKGROUND: 1-methylnicotinamide (1-MNA), an endogenous metabolite of nicotinamide, has recently gained interest due to its anti-inflammatory and anti-thrombotic activities linked to the COX-2/PGI(2) pathway. Given the previously reported anti-metastatic activity of prostacyclin (PGI(2)), we aimed to assess the effects of 1-MNA and its structurally related analog, 1,4-dimethylpyridine (1,4-DMP), in the prevention of cancer metastasis. METHODS: All the studies on the anti-tumor and anti-metastatic activity of 1-MNA and 1,4-DMP were conducted using the model of murine mammary gland cancer (4T1) transplanted either orthotopically or intravenously into female BALB/c mouse. Additionally, the effect of the investigated molecules on cancer cell-induced angiogenesis was estimated using the matrigel plug assay utilizing 4T1 cells as a source of pro-angiogenic factors. RESULTS: Neither 1-MNA nor 1,4-DMP, when given in a monotherapy of metastatic cancer, influenced the growth of 4T1 primary tumors transplanted orthotopically; however, both compounds tended to inhibit 4T1 metastases formation in lungs of mice that were orthotopically or intravenously inoculated with 4T1 or 4T1-luc2-tdTomato cells, respectively. Additionally, while 1-MNA enhanced tumor vasculature formation and markedly increased PGI(2) generation, 1,4-DMP did not have such an effect. The anti-metastatic activity of 1-MNA and 1,4-DMP was further confirmed when both agents were applied with a cytostatic drug in a combined treatment of 4T1 murine mammary gland cancer what resulted in up to 80 % diminution of lung metastases formation. CONCLUSIONS: The results of the studies presented below indicate that 1-MNA and its structural analog 1,4-DMP prevent metastasis and might be beneficially implemented into the treatment of metastatic breast cancer to ensure a comprehensive strategy of metastasis control. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13046-016-0389-9) contains supplementary material, which is available to authorized users. BioMed Central 2016-07-13 /pmc/articles/PMC4944260/ /pubmed/27412454 http://dx.doi.org/10.1186/s13046-016-0389-9 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Blazejczyk, Agnieszka Switalska, Marta Chlopicki, Stefan Marcinek, Andrzej Gebicki, Jerzy Nowak, Marcin Nasulewicz-Goldeman, Anna Wietrzyk, Joanna 1-methylnicotinamide and its structural analog 1,4-dimethylpyridine for the prevention of cancer metastasis |
title | 1-methylnicotinamide and its structural analog 1,4-dimethylpyridine for the prevention of cancer metastasis |
title_full | 1-methylnicotinamide and its structural analog 1,4-dimethylpyridine for the prevention of cancer metastasis |
title_fullStr | 1-methylnicotinamide and its structural analog 1,4-dimethylpyridine for the prevention of cancer metastasis |
title_full_unstemmed | 1-methylnicotinamide and its structural analog 1,4-dimethylpyridine for the prevention of cancer metastasis |
title_short | 1-methylnicotinamide and its structural analog 1,4-dimethylpyridine for the prevention of cancer metastasis |
title_sort | 1-methylnicotinamide and its structural analog 1,4-dimethylpyridine for the prevention of cancer metastasis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944260/ https://www.ncbi.nlm.nih.gov/pubmed/27412454 http://dx.doi.org/10.1186/s13046-016-0389-9 |
work_keys_str_mv | AT blazejczykagnieszka 1methylnicotinamideanditsstructuralanalog14dimethylpyridineforthepreventionofcancermetastasis AT switalskamarta 1methylnicotinamideanditsstructuralanalog14dimethylpyridineforthepreventionofcancermetastasis AT chlopickistefan 1methylnicotinamideanditsstructuralanalog14dimethylpyridineforthepreventionofcancermetastasis AT marcinekandrzej 1methylnicotinamideanditsstructuralanalog14dimethylpyridineforthepreventionofcancermetastasis AT gebickijerzy 1methylnicotinamideanditsstructuralanalog14dimethylpyridineforthepreventionofcancermetastasis AT nowakmarcin 1methylnicotinamideanditsstructuralanalog14dimethylpyridineforthepreventionofcancermetastasis AT nasulewiczgoldemananna 1methylnicotinamideanditsstructuralanalog14dimethylpyridineforthepreventionofcancermetastasis AT wietrzykjoanna 1methylnicotinamideanditsstructuralanalog14dimethylpyridineforthepreventionofcancermetastasis |